Can “G1” Withdrawal Scheme Be Improved Enough to Serve Its Purpose?

August 23, 2023
More than five years have passed since the rollout of the so-called “G1 withdrawal” scheme in the FY2018 drug pricing overhaul. As of April 2022, 267 long-listed products (LLPs) had been designated as G1 products, but withdrawals have been determined...read more